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Abstract
Background: Many recent studies of the effects of amyloid-b protein (Ab) on brain tissue from amyloid precursor protein
(APP) overexpressing mice have concluded that Ab oligomers in the extracellular space can profoundly affect synaptic
structure and function. As soluble proteins, oliomers of Ab can diffuse through brain tissue and can presumably exit acute
slices, but the rate of loss of Ab species by diffusion from brain slices and the resulting reduced concentrations of Ab species
in brain slices are unknown.
Methodology/Principal Findings: Here I combine measurements of Ab1–42 diffusion and release from acute slices and
simple numerical models to measure the concentration of Ab1–42 in intact mice (in vivo) and in acute slices from CRND8
mice. The in vivo concentration of diffusible Ab1–42 in CRND8 mice was 250 pM at 6 months of age and 425 pM at 12
months of age. The concentration of Ab1–42 declined rapidly after slice preparation, reaching a steady-state concentration
within one hour. 50 mm from the surface of an acute slice the steady-state concentration of Ab was 15–30% of the
concentration in intact mice. In more superficial regions of the slice, where synaptic physiology is generally studied, the
remaining Ab is less than 15%. Hence the concentration of Ab1–42 in acute slices from CRND8 mice is less than 150 pM.
Conclusions/Significance: Ab affects synaptic plasticity in the picomolar concentration range. Some of the effects of Ab
may therefore be lost or altered after slice preparation, as the extracellular Ab concentration declines from the high
picomolar to the low picomolar range. Hence loss of Ab by diffusion may complicate interpretation of the effects of Ab in
experiments on acute slices from APP overexpressing mice.
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Introduction
Amyloid-b protein (Ab) molecules aggregate in solution,
forming soluble oligomers and insoluble aggregates [1–3]. The
latter are a major component of senile plaques, a hallmark of
Alzheimer’s disease (AD). The discovery that neurodegeneration
and cognitive impairment correlate only weakly with plaque count
and more strongly with soluble or total Ab load has led to renewed
appreciation of the deleterious effects of soluble forms of Ab
[4–11].
The effects of soluble Ab include impaired synaptic transmis-
sion, typically observed in mouse models in which point mutations
in the amyloid precursor protein (APP) or other AD-linked genes
lead to APP overexpression and Ab accumulation [12–21]. In
these mouse models, neurons and synapses are exposed to elevated
concentrations of Ab for months, but soluble Ab can also act
rapidly. For example, exposure to soluble Ab for a few minutes
impairs hippocampal synaptic plasticity [18,19,22–24]. Hence
both prolonged and rapid elevation of the extracellular concen-
tration of soluble Ab species can alter neuronal function.
Much of our understanding of the effects of Ab on cellular and
synaptic function originates from experiments on acute brain
slices, prepared from APP overexpressing mice. Acute slices are
often used to study synaptic physiology as cells and synapses are
accessible and many short-range synaptic connections remain
intact. One potential problem is the loss of Ab after slice
preparation. Soluble Ab species are mobile in solution and
extracellular soluble Ab may exit slices by diffusion. Hence soluble
Ab is presumably lost from slices and the steady-state concentra-
tion of extracellular Ab in an acute slice is likely to be lower than
that in the brains of intact mice (in vivo). However, neither the
steady-state concentrations of Ab monomers and oligomers nor
the kinetics of the decline in extracellular Ab concentration have
been determined in acute slices from APP overexpressing mice.
Here I use simple numerical models, fluorescence microscopy
and enzyme-linked immunosorbent assays (ELISAs) to determine
the extracellular concentration of soluble Ab1–42 in acute slices
from CRND8 mice. I find that the extracellular Ab1–42
concentration is elevated after slice preparation, but rapidly
declines below the initial concentration, reaching steady-state
within ,30–60 minutes. Hence in slice physiology experiments, in
which measurements are typically made 30 minutes to several
hours after slice preparation, the extracellular concentration of
soluble Ab1–42 is a small fraction of the in vivo concentration,
raising the possibility that some of the effects of extracellular
soluble Ab species are absent or attenuated.
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Rate of diffusion of Ab in brain tissue
The rate of diffusion of a particle in solution is determined by its
diffusion coefficient (D). The diffusion coefficient for amyloid-b
(Ab) monomer in aqueous solution at 25uC has been estimated
from NMR measurements as between 1.4610
26 and 2.1610
26
cm
2/s [25,26]. The diffusion coefficient is linearly dependent on
absolute temperature and is therefore approximately 4% greater at
37uC than at 25uC. Hence the literature indicates that the
diffusion coefficient for Ab monomer in aqueous solution at 37uC
is approximately 1.8610
26 cm
2/s and this is the value used here.
Diffusion in brain tissue is impeded by a variety of barriers,
including cells and extracellular matrix. The effective diffusion
coefficient (Deff) in brain tissue is related to the diffusion coefficient
for free diffusion by:
Deff~D=l
2 ð1Þ
where l is the tortuosity factor.
Forbraintissue,lis,1.7[27,28].HenceDeff=0.623 610
26 cm
2/s
for Ab monomer in brain tissue at 37uC.
The distribution of Ab after release from a point source may be
calculated using the following equation [27,29]:
C~
s
4ptDeff
 3
2
:e
{ r2
4tDeff

ð2Þ
where C is the concentration of the diffusing species
S is the amount of the diffusing species
Deff is the effective diffusion coefficient
t is time
r is the distance (radius) of diffusion in three dimensions
Random walk model of Ab diffusion
The distribution of Ab monomer (calculated using equation 2)
as a function of distance from a point source (distance=0) after
1ms of diffusion is shown in figure 1A. Integration of this curve
from the point of release to infinity gives the cumulative
probability of finding a single molecule of Ab with increasing
distance from the point of release (figure 2B). (Note that the
cumulative probability approaches 0.5 as distance tends towards
infinity. This is because half of the particles diffuse towards infinity
and half in the opposite direction, towards minus infinity.)
From the cumulative probability plot shown in figure 2B I
derived the median radius of diffusion (r). The median radius is the
distance traveled by half the molecules, i.e. cumulative probabil-
ity=0.25. For Ab monomer in brain tissue, the median radius of
diffusion in 1 ms is 238nm. Hence half of the diffusing Ab
molecules are found between +238 and 2238 nm of the point
source 1ms after their release.
In the model Ab diffuses from brain tissue into ACSF or a layer
of agarose. Tissue, ACSF and agarose are homogenous media
separated by planar boundaries that are parallel to each other and
the concentrations of Ab are uniform across each plane parallel to
these boundaries (and perpendicular to the axis of diffusion). This
greatly simplifies the model since Ab that moves laterally away
Figure 1. Random-walk model of Ab diffusion in brain tissue.
(A) Distribution of Ab monomer 1ms after release from a point source
(at distance=0). The concentration of Ab is given in arbitrary units (au).
Curve calculated using equation 2, with Deff=0.623610
26 cm
2/s. (B)
Cumulative distribution of Ab monomer 1ms after release from a point
source (at distance=0), derived by integrating the curve in panel A
from zero to infinity. Half the diffusing molecules (cumulative
probability 0.25) are within 238 nm of the point source. (C) Calculation
of mean diffusion distance in one dimension from that in three
dimensions. A particle is released from a point source. In time=t, it
diffuses a mean distance of r (black arrow) in a random angle (h) to the
axis of diffusion (dashed line). The mean distance of diffusion in one
dimension (r9; black arrow) occurs when h=45u.( D) Diffusion of four
molecules through two iterative steps of the random walk model. At
each step half of the molecules in each location move r9 towards infinity
and half towards negative infinity.
doi:10.1371/journal.pone.0015709.g001
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calculated using an effective diffusion coefficient of 0.623610
26 cm
2/s for monomer and 0.216610
26 cm
2/s for 24mer. Distributions are shown (on
two different scales) for 100, 200, 300, 500, 1000 and 2000 ms after release from a point source. Concentrations are given in arbitrary units (au). (B)
Plots showing the decrease in peak amplitude and increase in width of the Gaussian distributions during the first two seconds after release from a
point source, calculated for monomer and 24mer. (C) Schematic showing the orientation of the 2-photon line scan with respect to the pipette
containing fluorescent Ab1–42 (green fill). Fluorescence was measured repeatedly by scanning the laser excitation repeatedly along a line (line scan)
oriented perpendicular to the long axis of the pipette. Fluorescent Ab1–42 was ejected into the tissue (green circle) by the application of pressure to
the rear of the pipette (arrow). (D) Result of one trial, showing the increase in fluorescence intensity following pressure ejection of fluorescent Ab1–42.
Distance along the scanned line is shown on the vertical axis and time on the horizontal axis. The distributions of fluorescence along the line is shown
in panel E for the 5 marked points in time (arrow heads). (E) Fluorescence intensities (green) and Gaussian fits (black) for the five time points indicated
in panel F. Fluorescence intensity is displayed in arbitrary units (au). (F) The amplitude and width of the Gaussian fits, plot as a function of time, for
the trial shown in panel D. Fluorescent Ab1–42 was ejected from the pipette with a single 20 ms pulse of pressure at the arrow head. The fluorescence
amplitude peaked several milliseconds later (dashed line). The widths of the Gaussian fits were variable before pressure ejection because the fits to
the low background fluorescence (probably autofluorescence of the slice and leakage of fluorescence from the pipette tip) were variable. During and
after pressure ejection the width became more consistent, indicating reliable Gaussian fits, as seen in panel E. The width of the Gaussian fits increased
over time. For comparison, the expected rates of expansion of the widths of the Gaussian fits, starting from the time at which the fluorescence
intensity peaked, were calculated for monomer and 24mer and are overlaid in red.
doi:10.1371/journal.pone.0015709.g002
Ab Diffusion from Acute Slices
PLoS ONE | www.plosone.org 3 December 2010 | Volume 5 | Issue 12 | e15709from the axis of diffusion will, on average, be replaced by an equal
amount of Ab moving towards the axis of diffusion. Hence
diffusion can be described using a relatively simple one-
dimensional model with the axis of diffusion perpendicular to
the boundaries between tissue, ACSF and agarose. However, the
radius of diffusion calculated from equation 2 is for diffusion in
three dimensions. I therefore converted the radius of diffusion (in 3
dimensions) to an equivalent distance of diffusion in one
dimension, along the axis (r9). This is illustrated in figure 2C. In
time=t, a particle diffuses distance r (grey arrow) in a random
direction, i.e. at a random angle h with respect to the axis of
diffusion in one dimension (dashed line in figure 2C). Hence after
time=t, the particle is at a random location on the surface of a
sphere of radius r (drawn as a circle in figure 2C). On average the
particle travels at 45 degrees to the axis of diffusion in one
dimension (there being an equal number of angles between h and
zero and h and 90 degrees and, therefore and equal probability of
h being less and greater than 45 degrees). The mean distance
traveled along the axis of diffusion in one dimension (r9) will
therefore be
r’~ r2
2
 1=2
Hence the mean distance of one-dimensional diffusion of Ab in
1 ms (for which r=238 nm) is 168 nm.
One-dimensional random-walk models were constructed to
quantify diffusion. Diffusion was simulated as a series of stepwise
displacements of Ab, where in each time-step half of the material
moved towards infinity and the other half towards negative
infinity. This is illustrated in figure 2D in which the position of 4
molecules are shown at three subsequent time points. Calculations
were performed with 5–10 nm spatial resolution and 1 ms to 1 s
time steps.
Ab multimers were assumed to diffuse as globular proteins, for
which
Dmultimer~Dmonomer

n1=3
where n is the number of monomers that aggregate to form the
multimer.
Hence for an oligomer composed of 24 monomers (24mer),
D=0.624610
26 cm
2/s and Deff=0.216610
26 cm
2/s.
Constant turn-over of Ab was included in some model
calculations by adjusting the concentrations of Ab at every
location within the tissue after each iterative step of the model.
Monomer and oligomers were all assumed to turn-over at a
constant rate of 0.015% per second (unless otherwise stated) which
corresponds to a half-life of 1.28 hours. Published measurements
for the half-life of Ab are 0.7 to 3.8 hours in mice [30,31] and ,8–
9 hours in human CNS [32].
Several similar models were employed to calculate Ab
concentrations under slightly different conditions. Model #1
simulated a brain slice bathed in a practically infinite volume of
circulating ACSF, such as in a large-volume holding chamber.
After each iterative step of this model, Ab that had exited the slice
into the ACSF was eliminated from the model. Diffusion of Ab
from the brain in an intact mouse was simulated in model #2, in
which the brain surface was covered with a layer of agarose. Ab
exiting the brain entered the agarose. Diffusion through the
agarose was modeled as diffusion in free solution, using a diffusion
coefficient of 1.8610
26 cm
2/s for Ab monomer and 0.624610
26
cm
2/s for 24mer. A half-life for Ab of 1.28 hours was employed in
model #2. Model #3 simulated a variable ‘recovery’ period and
subsequent ‘measurement’ period. The tissue concentration of Ab
was first calculated (using model #1) during a recovery period in
which the slice was in a practically infinite volume of circulating
ACSF. The slice was then transferred to a smaller-volume
chamber containing 250 ml ACSF, in which Ab which exits the
slice accumulates in the ACSF. The ACSF was assumed to be
well-mixed and after each iterative step Ab that had exited the
slice into the ACSF was therefore redistributed evenly throughout
the ACSF. Model #4 simulated a slice placed in a small-volume
chamber containing 250 ml ACSF immediately after preparation.
The ACSF was assumed to be well-mixed and after each iterative
step Ab that had exited the slice into the ACSF was therefore
redistributed evenly throughout the ACSF. Model #5 simulated
exogenous application of Ab to a slice. The initial concentration of
Ab in the slice was zero. The slice was bathed in an infinite volume
of Ab-containing ACSF and after each iterative step, the Ab
concentration in the ACSF was restored to 1. Turn-over of Ab was
excluded from this model.
Simplifying assumptions were used to calculate the rates of
diffusion across boundaries between media in which the diffusion
coefficients for Ab were different. In slice experiments the ACSF
was constantly stirred. In the corresponding models (#3 and #4) I
therefore assumed that the ACSF contained a homogenous
concentration of Ab. Hence at the end of each iteration of the
model, during which Ab would have been exchanged between
tissue and ACSF using the effective diffusion coefficient for the
tissue, the concentration of Ab at all locations in the ACSF was set
to the mean ACSF Ab concentration. In the in vivo model (#2), it
was necessary to simulate diffusion through across a tissue-agarose
boundary and through the agarose. After each iteration, the
concentration across all locations within one diffusion coefficient of
the boundary was averaged. To prevent any Ab crossing the
agarose-coverslip boundary, particles less than one diffusion
coefficient from the boundary were permitted to move only away
from the coverslip, 50% of the particles remaining stationary in
each step.
All simulations were implemented in Igor Pro 6.0 (Wavemetrics,
Eugene, OR) using custom-written routines. The code for model
#1 is available as supporting information (Code S1).
Diffusion of fluorescent Ab1–42 in acute slices
Diffusion of fluorescently labeled Ab1–42 (HiLyte Fluor 488
labeled Ab(1–42), Anaspec, Fremont, CA) was modeled using the
diffusion coefficients for unlabeled Ab1–42. This is an approxima-
tion since the fluorescent tag increases the relative molecular mass
of the molecule from 4514.1 to 4870.5, which presumably results
in a small reduction in the diffusion coefficient. When modeling
diffusion of fluorescent Ab1–42 I also assumed that there was no
turn-over of this molecule in brain tissue.
I measured diffusion of fluorescent Ab1–42 in acute slices. An
adult wild-type mouse was deeply anesthetized with isoflurane and
decapitated and the brain was rapidly removed into cold artificial
cerebrospinal fluid (ACSF). ACSF composition was (in mM): 125
NaCl, 2.5 KCl, 1.25 NaH2PO4, 20 NaHCO3, 5 HEPES, 25
Glucose, 2 CaCl2, 1MgCl2, pH 7.3, oxygenated with 95% O2/5%
CO2. Parasagittal slices 200 mm thick were prepared using a
vibrating slicer (Vibratome, St. Louis, MO) and maintained in the
above solution at room temperature for 2 hours before transfer to
the microscope stage. On the microscope stage the slice was
constantly perfused with the above solution at 35–37uC.
Fluorescence was measured by 2-photon fluorescence micros-
copy using a custom built microscope based on an Olympus BX51
frame. The specimen was illuminated with 840 nm light from a
Ti:sapphire laser (Chameleon Ultra, Coherent, 80 MHz repetition
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specimen using a 640, NA 0.8 or 620, NA 1.0 water-immersion
objective (Olympus, Center Valley, PA). Emitted light was
collected in the epifluorescence configuration through a 680 nm
dichroic reflector and an infrared-blocking emission filter
(ET700sp-2p, Chroma Technology, Bellows Falls, VT). Fluores-
cence was detected via a 490–560 bandpass filter (Chroma
Technology) using a photomultiplier tube (R6357, Hamamatsu).
Scanning and image acquisition were controlled using custom
software written in Labview (National Instruments, Austin, TX).
The rate of diffusion of fluorescent Ab1–42 was measured in
acute slices by 2-photon fluorescence microscopy. Fluorescent
Ab1–42 was applied locally by pressure ejection from a pipette.
HiLyte Fluor 488 labeled Ab(1–42) was dissolved at 100 mMi n
modified ACSF (in mM): 135 NaCl, 5.4 KCl, 1 MgCl2, 1.8
CaCl2, 5 HEPES, pH 7.3. A pipette with a tip diameter of ,1 mm
was filled with 100 mM fluorescent Ab1–42 and the tip was
positioned in stratum radiatum of the hippocampus, ,100 mm
below the surface of the slice. Fluorescent Ab1–42 was ejected from
the pipette with brief a pulse of positive pressure (10–50 ms, 20–
30 psi) controlled by a pressure ejector (Toohey Spritzer, Fairfield,
NJ). Fluorescence was measured a few mm from the pipette tip
using line scans, in which the tissue near the tip of the pipette was
scanned repeatedly at 2ms intervals by the excitation laser.
I also measured diffusive loss of fluorescent Ab1–42 from acute
slices. Slices were prepared as described above and immediately
placed into 50 mM fluorescently labeled Ab1–42 in modified
ACSF(in mM): 135 NaCl, 5.4 KCl, 1 MgCl2, 1.8 CaCl2, 5
HEPES, pH 7.3, oxygenated with 95% O2/5% CO2. Solution
was constantly stirred by placing the plate on an orbital shaker.
After 2 hours (to allow the concentration of fluorescent Ab1–42
throughout the slice to approach 50 mM), the slice was transferred
to the stage of the 2-photon microscope. The fluorescence within
the slice was imaged at regular intervals during perfusion with
ACSF (no Ab or fluorophore) warmed to 35–37uC.
Measuring loss of fluorescent Ab1–42 required repeated imaging
in the single location for up to ,1 hour. Hence photobleaching
and drift in x-, y- and z-axes could potentially confound the results.
To minimize photobleaching I used a relatively high concentration
of Ab1–42, which was bright enough to enable the use of low
intensity laser excitation. In addition after imaging the decline in
fluorescence through time I verified that the intensity in the
imaged region was similar to that in neighbouring regions of the
slice. The presence of identifiable structures in the image
throughout the imaging period suggested that drift was negligible,
particularly parallel to the optical axis of the microscope (x- and y-
axes). To further exclude the possibility of drift perpendicular to
the optical axis (z-axis) I checked that the slice surface was still
100 mm from the imaging site after measurements of fluorescence
through time were complete. Through these controls I ensured
that neither photobleaching nor drift in the relative position of the
slice and focal position effected these measurements significantly.
Measurement of Ab1–42 release from acute slices
Coronal slices 300 mm thick were prepared from CRND8 mice
as described above. To measure release of Ab species, each slice
was transferred to one well of a 24-well plate immediately after
preparation. The well contained 250 ml of modified ACSF (in
mM): 135 NaCl, 5.4 KCl, 1 MgCl2, 1.8 CaCl2, 5 HEPES,
pH 7.3, oxygenated with 95% O2/5% CO2. Solution was
constantly stirred by placing the plate on an orbital shaker.
Duplicate measurements of Ab1–42 concentration in the ACSF
were made using a sandwich enzyme-linked immunosorbent assay
(ELISA) kit (high sensitive human beta amyloid(1–42) ELISA kit,
Wako Chemicals, Richmond VA), which measures Ab1–42
concentrations in the 1–20 pM range. To correct for differences
in the volumes of individual slices, we measured the wet weight of
each slice at the end of the experiment and normalized Ab1–42
release to that of a 25 mg slice.
Hence Ab1–42 concentration was measured after release into a
relatively small volume of ACSF. 250 ml was selected as the
volume of ACSF as this was the smallest volume compatible with
duplicate measurements using the ELISA kit, which requires
100 ml per measurement. Hence the volume of a 25 mg slice was
10% of the volume of ACSF. Minimizing the volume of ACSF was
necessary as the total amount of Ab1–42 released from a brain slice
is likely to be small.
In some experiments slices were pre-washed in ACSF before the
measurement of Ab1–42 release into ACSF. The pre-wash
consisted of incubating the slices in a large volume (,250 ml) of
constantly-circulating ACSF at 35uC.
Totals numbers of mice used in these experiments, by age
range, were: two P96–114; six P127–144, three P152–163; two
203–233.
Measurement of Ab release in vivo
To measure the extracellular diffusible Ab1–42 concentration in
vivo (i.e. in intact animals) I implanted a small chamber over frontal
cortex, placed a small volume of agarose in the chamber and in
contact with the brain for 48 hours and later assayed the
concentration of Ab1–42 in the agarose.
A mouse was deeply anesthetized with isoflurane (2–2.5%,
inhaled) such that pinch-withdrawl and palpebral reflexes were
eliminated. The skin was reflected and a small aluminium plate
was attached to the skull with dental acrylic. A large craniotomy
(diameter ,5–6 mm) was opened over frontal cortex, centered
,1 mm posterior to bregma. The brain was covered with 40–
60 mg of 0.75–1% agarose (w/v) in ACSF. The craniotomy and
agarose were covered with an 8 mm-diameter coverslip and sealed
using dental acrylic. The mouse was allowed to recover and was
returned to its home cage.
The model predicts that the concentrations of diffusible
extracellular Ab species in the agarose are close to the
concentrations in brain tissue after ,30 hours and the mouse
was therefore left in its home cage for ,60 hours. It was then re-
anesthetized. The agarose was collected and placed in 350 mlo f
ACSF for $4 hours, which is sufficient for the Ab1–42 to diffuse
into the ACSF and reach an equilibrium concentration. The
ACSF was then collected, diluted (to bring the final ACSF Ab1–42
concentration into the appropriate range for the ELISA kit) and its
Ab1–42 content was determined with the ELISA kit. The agarose
was subsequently weighed to determine the dilution factor into
ACSF and thereby calculate the concentration of Ab1–42 in brain
tissue.
A total of 9 mice were used for in vivo experiments, with ages
from P100 to P370.
Results
Rate of diffusion of Ab1–42 in brain tissue
To model the diffusion of Ab out of a brain slice, we need to
know the effective diffusion coefficient of Ab in brain tissue. The
diffusion coefficient for Ab1–42 monomer in aqueous solution is
available from the published literature and from this value the
effective diffusion coefficient of Ab1–42 monomer in brain tissue
was estimated at 0.623610
26 cm
2/s (see Methods section).
Soluble forms of Ab include monomers and oligomers of up to
24 monomers [1] (24mers). Hence I also considered diffusion of
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tissue of 0.216610
26 cm
2/s (see Methods section). To verify that
these estimates of effective diffusion coefficients accurately
represent diffusion of Ab1–42 in the brain, I measured the diffusion
of fluorescently-tagged Ab1–42 in hippocampal tissue and com-
pared the spread of fluorescent Ab1–42 with the calculated
distribution expected from theory.
I first calculated the expected distribution of Ab1–42 in brain
tissue after release from a point source. This distribution is
Gaussian, with the concentration declining from a peak at the site
of release. As molecules diffuse away from the source of release
over time, the shape of the distribution remains Gaussian, with the
peak amplitude declining and the width increasing with time
(figure 2A and 2B). The amplitude and width of the Gaussian
distribution at any moment in time will depend on the diffusion
coefficient of the diffusing species. I therefore calculated the
expected distributions for both monomer and 24mer using their
respective diffusion coefficients.
I then measured the rate of diffusion of fluorescent Ab1–42 in the
acute hippocampal slice. A pipette with a tip diameter of ,1 mM
was filled with 100 mM fluorescent Ab1–42 (in ACSF) and was
inserted into stratum radiatum, such that the tip was ,100 mm
below the surface of the slice. A small volume of fluorescently-
tagged Ab1–42 was ejected into the slice by the brief application of
pressure (10–50 ms, 20–30 psi). The diffusion of Ab1–42 through
the tissue near the tip of the pipette was measured by 2-photon
fluorescence microscopy (figure 2C and 2D).
During pressure ejection the fluorescence intensity near the tip
of the pipette increased rapidly, reaching a peak a few milliseconds
after ejection ended (figure 2D–F). As expected, the fluorescence
intensity was well-described by a Gaussian distribution with the
peak of the fluorescence close to the tip of the pipette. Furthermore
the peak amplitude declined and the width increased with time
(figure 2D–F). Hence pressure ejection of Ab1–42 approximates
release of Ab1–42 from a point source. Importantly, the rate at
which the width of the Gaussian fit increased was similar to that
expected from theoretical calculations (figure 2F). I measured
diffusion in 6 locations, following Ab1–42 diffusion for 7056
145 ms, during which time the width of the Gaussian fit increased
from 6.561.0 mm to 13.762.46 mm. By comparison, expansion of
the Gaussian distribution from 6.5 to 13.7 mm was expected, from
theoretical calculations, to take 580 ms for monomer and
1.68 seconds for 24 mer. Hence these measurements confirm that
Ab1–42 diffuses rapidly through the extracellular space in brain
tissue and that this diffusion can be accurately modeled using
effective diffusion coefficients of 0.623610
26 cm
2/s for monomers
and 0.216610
26 cm
2/s for 24mers of Ab1–42.
Model predicts substantial loss of extracellular diffusible
Ab species from acute brain slices within 1 hour
Using these diffusioncoefficients,I calculated the expected rateof
loss of diffusible Ab species from the extracellular space of an acute
slice, using a simple random walk model of diffusion. The aim was
to model loss of Ab in slice physiology experiments, such as
experiments in which many investigators have studied the effects of
Ab species on synaptic transmission. In such experiments, the brain
is typically cut into slices that are 200- to 400 mm-thick and these
slices are then incubated in a large volume of ACSF for 30 minutes
to several hours before electrophysiological recordings are obtained.
I therefore modeled diffusion from a 300 mm-thick section of tissue,
bathed on both sides by ACSF (figure 3A). Ab which exited the
tissue into the ACSF was instantly removed. The initial concentra-
tions of Ab wereone in tissue and zero in ACSF (figure 3B), with the
result that all concentrations in the model are normalized to the
initial concentration of Ab in the extracellular space. Using this
approach I calculated the concentrations of monomer and 24mer
throughout the slice (figure 3C–H).
Ab concentrations were first calculated for the simplest scenario,
in which Ab is not gained or lost (other than by diffusion) from the
tissue (no turn-over; figure 3C, D). However, both Ab1–42 and
Ab1–40 have relatively short half-lives in the CNS (0.7 to 4 hours in
APP overexpressing mice [30,31]). Hence Ab concentrations were
also calculated with constant turn-over of Ab, assuming a half-life
of Ab of 1.28 hours (figure 3E,F). In both scenarios, the
concentrations of monomer and 24mer were greatly reduced at
the edges of the slice within a minute of slice preparation
(figure 3C–F). Even deep in the slice, the concentrations of
monomer and 24mer were dramatically reduced. Monomer
reached a steady-state concentration throughout the slice in 30–
60 minutes and 24mer after 1–2 hours (figure 3G,H). Hence the
model predicts that the diffusive loss of Ab from the extracellular
space in an acute slice is rapid and profound.
Loss of fluorescently-tagged Ab1–42 from acute brain
slices
To confirm that soluble Ab is indeed rapidly lost from the
extracellular space in acute slices I loaded acute slices with
fluorescent Ab1–42 and monitored the decline in intensity as
fluorescent Ab1–42 diffused out of the slice. Immediately after
preparation acute slices were placed in ACSF containing 50 mM
fluorescent Ab1–42. After 2–3.5 hours (long enough for the
concentration of fluorescent Ab1–42 in the extracellular space to
approach 50 mM; see ‘Kinetics of exogenous Ab accumulation in
slices’ section, below) the slice was placed on the stage of the 2-
photon microscope and the fluorescence intensity 100 mM below
the upper surface of the slice was monitored for up to ,1 hour as
the slice was perfused with fresh ACSF, containing no Ab or
fluorophore. As expected the fluorescence intensity declined with
time (n=3 slices; figure 4). Furthermore, the decline in intensity
with time matched the rate of loss of Ab expected from the model
(figure 4B), occurring with a time constant of 18.067.0 minutes
(n=3 slices). I conclude that extracellular Ab is lost rapidly
from acute slices with the time course predicted by the diffusion
model.
The concentration of diffusible extracellular Ab1–42 in
CRND8 mice in vivo
Hence it seems likely that endogenous soluble Ab species are
rapidly lost from the extracellular space in acute slices with the
time course predicted by the model, but the diffusion of fluorescent
Ab1–42 might differ from that of endogenous Ab1–42. For example,
the fluorescence tag might affect diffusion or the high concentra-
tion of fluorescent Ab1–42 that was, necessarily, added to the slice
might stimulate or saturate pathways of Ab metabolism or
clearance. I therefore sought to determine the rate of loss of
Ab1–42 from acute slices from CRND8 mice, which overexpress
APP and accumulate Ab1–42 in the hippocampus and neocortex.
The concentration of endogenous Ab1–42 in the extracellular space
of an acute slice is difficult or perhaps impossible to measure
directly. My aim was therefore to combine the model with
measurements of Ab1–42 release from acute slices to determine
what proportion of diffusible Ab remains in the extracellular space
as a function of time after slice preparation.
First I measured the concentration of diffusible, extracellular
Ab1–42 in the intact brain. A craniotomy was cut over frontal cortex
and a small reservoir of agarose was placed in contactwiththe brain
surface. In this preparation Ab species diffuse from the brain and
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the agarose increase until their concentrations equal those in the
brain. The agarose was then removed and the concentration of
Ab1–42 in the agarose was measured with an ELISA kit.
First the numerical model was employed to estimate the
duration for which agarose needs to be in contact with the brain
for the concentration of Ab in the agarose to reach steady-state.
The model (#2) simulated diffusion from the brain into a 1 mm–
thick layer of agarose (figure 5A). As in the previous model, the
tissue Ab concentration was initially set to 1 and the concentration
in agarose to 0, thereby normalizing Ab concentrations to the
initial tissue concentration (figure 5B). In the model, the Ab
concentration in the superficial millimeter of brain tissue declined
rapidly as Ab was lost by diffusion into the agarose (figure 5C).
The model predicts that after 30 hours, the concentrations of Ab
in the agarose would be 97% and 82% of the initial Ab
concentration in the brain for monomer and 24mer, respectively
(figure 5D). In experiments, agarose was therefore placed in contact
with the brain surface for ,60 hours ensure that the Ab
concentration in the agarose was an accurate reflection of the
concentration in the brain. The concentration of Ab1–42 in the
agarose, and therefore of extracellular soluble Ab1–42 in the brain,
increased with age (figure 5E). Mean concentrations were derived
from a regression line and were 160 pM at 3 months, 250 pM at 6
months and 425 pM at 12 months of age (figure 5E). These are the
first measurements of the concentration of soluble Ab in the
extracellular space in CRND8 mice. The results indicate that the
concentration of soluble Ab1–42 in the extracellular space increases
Figure 3. Model predicts rapid loss of diffusible Ab from acute brain slices. (A) Schematic illustration of model #1, in which a 300 mm-thick
tissue slice is bathed in a large volume of ACSF, as commonly employed in slice physiology and imaging experiments. We calculated diffusion in the
vertical axis (dashed line). (B) Initial concentration of Ab as a function of location. Tissue-ACSF boundaries are at distances of +150 and 2150 mm.
Initial concentration in the tissue is 1, with the result that all concentrations in the model are normalized to the initial concentration in brain tissue. (C
and D) Concentrations of monomer (C) and 24mer (D) at all locations in the brain slice (plot as a function of distance from the center of the brain
slice) at 1 minute, 10 minutes, 30 minutes, 1 hour, 2 hours and 3 hours in the absence of Ab turn-over. (E and F) Concentrations of monomer (E) and
24mer (F) at all locations in the brain slice (plot as a function of distance from the center of the brain slice) at 1 minute, 10 minutes, 30 minutes,
1 hour, 2 hours and 3 hours with a half-life for Ab of 1.28 hours. (G and H) Concentrations of monomer (G) and 24mer (H) as a function of time at
three different locations within the brain slice. Distances (0, 50, 100 mm) are with respect to the center of the slice. Red lines: no turn-over of Ab; blue
lines: half-life of 1.28 hours.
doi:10.1371/journal.pone.0015709.g003
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homogenates and in plasma (Chishti et al., 2001; Phinney et al.,
2003; Hyde et al., 2005).
Release of Ab1–42 from slices is greater than expected
from the model
Next I measured the amount of Ab1–42 released from acute
brain slices from CRND8 mice. In physiology experiments, slices
are typically cut from the brain and allowed to recover from the
slicing process for at least 30 minutes, often several hours, before
further use. To mimic a typical slice physiology experiment, after
preparation, slices were placed in a large-volume holding chamber
for 15–120 minutes (hereafter referred to as the recovery period).
Slices were then transferred to a smaller chamber containing
250 ml ACSF and after 30 minutes the concentration of Ab1–42 in
the ACSF was measured using an ELISA kit.
The concentration of Ab1–42 in the ACSF was between 4 and
8 pM for slices from 4.5 month-old (P132) mice (figure 6A) and, as
expected, the amount of Ab1–42 released from slices from older
mice was greater, at 11–15 pM for 5.5 month-old (P163) mice
(figure 6A). The duration of the recovery period had little effect on
the amount of Ab1–42 released during the measurement period
(figure 6A). This weak effect of the recovery period on the Ab1–42
concentration in the ACSF is expected from the model, in which
the Ab concentration in the slice declines rapidly towards a steady-
state concentration, in around 30 minutes. The steady-state
concentrations of Ab1–42 in ACSF (mean 6 SEM of concentra-
tions after 60, 90 and 120 minute recovery periods) were
7.060.4 pM for P132 mice and 13.061.1 pM for P163 mice.
These concentrations are 3.5% and 5.6%, respectively, of the
concentrations in vivo at these ages (calculated from the regression
line in figure 5E), yielding a mean normalized concentration of
Ab1–42 in ACSF bathing slices of 0.045.
The measured concentrations of Ab1–42 in the ACSF are greater
than expected from the model. The model (#3) predicts that the
normalized concentration of Ab1–42 in the ACSF with a 60–
120 minuterecoveryperiodwillbe0.026forthemonomer(figure6B)
and 0.025 for the 24mer (not shown). Ab1–42 in vivo at P132 and P163
were 203 and 234 pM. Hence the expected concentrations of Ab1–42
in ACSF are 5.2 and 6.0 pM for P132 and P163 mice (figure 6B) and
more Ab1–42 is released into the ACSF than expected.
Could the rate of diffusion of endogenous Ab1–42 be greater
than expected and might this result in a greater concentration of
Ab1–42 in the ACSF than predicted by the model? In the model I
examined the effect of changing the effective diffusion coefficient
on the concentrations of Ab in the ACSF and tissue. Both
doubling and halving the effective diffusion coefficient affected the
tissue concentration of Ab, but neither doubling nor halving the
effective diffusion coefficient had substantial effects on the
expected concentration of Ab1–42 in the ACSF (figure 6B and
C). Similar effects were observed for both monomer (figure 6B and
C) and 24mer (not shown). Hence even large changes in the rate of
diffusion do not increase the expected concentration of Ab1–42 in
the ACSF. An erroneous rate of diffusion of Ab in the model is
therefore unlikely to account for the difference between expected
and measured concentrations of Ab1–42 in the ACSF.
Half-life of Ab1–42 in acute slices from CRND8 mice
In the model we initially used a half-life for Ab of 1.28 hours. If
the half-life of Ab1–42 in acute slices is shorter than 1.28 hours,
reflecting a greater rate of synthesis and/or release of Ab1–42, the
rate of release of Ab1–42 from the slice might be elevated and the
concentration of Ab1–42 in the ACSF increased. This might
explain the difference between expected and measured concen-
trations of Ab1–42 in the ACSF.
Reducing the half-life of Ab in the model increased the
concentration of Ab released into the ACSF (figure 7A) with the
expected concentration of Ab in the ACSF increasing approxi-
mately exponentially with decreasing half-life (figure 7B). The
expected Ab concentrations were calculated separately for
monomer and 24mer and comparison with the measured Ab1–42
concentrations revealed that the measured concentrations were
similar to expected concentrations when the half-life was
approximately 0.64 hours (figure 7A).
By adjusting the half-life of Ab used in the model, the expected
concentration in the ACSF can be matched to the measured
ACSF concentration of Ab1–42. From the measurements in brain
slices (figure 6A) the mean normalized concentration of Ab1–42 in
ACSF was 0.045 (calculated above). In the model, a steady-state
normalized ACSF Ab concentration of 0.045 occurs at half-lives of
0.67 and 0.52 hours for monomer and 24mer, respectively. Hence
the model best fits the measured concentrations of Ab1–42 when
the half-life of Ab in the model is 0.52–0.67 hours.
The steady-state Ab concentration in a slice is ,20% of
the concentration in vivo
From the model and measurements, it is possible to estimate the
tissue concentrations of Ab. For simplicity, in figure 7A and B
tissue Ab concentration is displayed as an average of the Ab
concentration throughout the thickness of the slice. Tissue
concentrations of Ab are consistently greater than ACSF
concentrations and, like ACSF concentrations, increase approx-
imately exponentially with decreasing half-life. With a half-life of
0.64 hours, the normalized tissue concentrations of Ab (averaged
throughout the depth of the slice) were 0.16 and 0.36 for monomer
Figure 4. Loss of fluorescent Ab1–42 from acute slices. (A) Three
2-photon fluorescence images acquired from a focal plane 100 mm
below the surface of an acute slice. The slice was pre-incubated with
50 mM fluorescent Ab1–42 in ACSF for 3.5 hours and a series of images
were acquired over the subsequent hour, during perfusion of the slice
with Ab-free ACSF. From left to right, these images were acquired after
6.37, 26.7 and 60.1 minutes of perfusion with Ab-free ACSF. (B) Time
course of the decline in fluorescence with time in Ab-free ACSF for the
site shown in panel A. Each point represents intensity in one image. The
decay in fluorescence was fit with an exponential with a time constant
of 25.2 minutes (black line). The expected rates of loss of monomer and
24mer (normalized to the initial intensity in the first image), calculated
using the diffusion model (model #1; figure 3), are shown in red. Arrow
heads indicate the three images in panel A.
doi:10.1371/journal.pone.0015709.g004
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inate in CRND8 mice, the mean tissue concentration of Ab at
steady state in an acute slice is likely to be towards the lower end of
this range, around 20% of the in vivo concentration.
In slices, a concentration gradient of Ab will presumably exist,
with relatively high concentrations of Ab species deep in the slice
and lower concentrations towards the edges of the slice. From the
model we calculated these concentration gradients for both
monomer and 24mer, using a half-life of 0.64 hours (figure 7D).
The highest concentration of Ab will be at the center of the slice.
The concentration of monomer at the center of the slice was 23%
of the initial concentration. Hence physiology experiments will
typically report the properties of cells and synapses in relatively
low concentrations of extracellular soluble Ab. This problem may
be particularly acute with whole-cell recordings, which are
typically obtained from somata approximately 50 mm from the
cut surface of the slice. 50 mm from the edge of the slice, the
concentration of monomer was 15% of the initial concentration.
For 24mer, the concentration at the center of the slice was 45%
and 50 mm from the edge of the slice was 28% of the initial
concentration. Hence the concentrations of soluble Ab throughout
the slice are low and in the superficial regions of the slice, where
most whole-cell electrophysiological recordings are obtained,
concentrations are likely to be extremely low: probably 10–20%
of the concentration of Ab in vivo.
Kinetics of the changes in Ab concentration after slice
preparation
Having determined that most of the extracellular soluble Ab is
eventually lost from acute brain slices, I next investigated the rate
at which the Ab concentration approaches steady-state after slice
preparation.
Figure 5. Diffusible extracellular Ab concentration in vivo. (A) Schematic illustration of model #2, which simulates diffusion of Ab in the intact
mouse brain and overlying agarose. The model included 2mm of brain tissue and 1 mm of agarose sealed with a coverslip. We calculated diffusion in
the vertical axis (dashed line). (B) Initial concentration of Ab as a function of location. The tissue-agarose boundary is at 2 mm. Initial concentration in
the tissue is 1, with the result that Ab concentration is normalized to the initial concentration in brain tissue. (C) Concentrations of monomer and
24mer (plot as a function of location) at 1 second, 1, 10 and 30 minutes, 1, 2, 3, 5, 10 and 30 hours. Half-life of Ab was 1.28 hours. Black lines highlight
concentrations at 1 hour and 10 hours. (D) Mean concentration of Ab in the agarose, plot against time, for monomer and 24mer. After 30 hours
monomer and 24mer are 96.5% and 82.2%, respectively, of the initial tissue concentration. Solid lines are double exponential fits to the results. Both
curves are dominated by one exponential term with time constants of 8.9 hours for the monomer and 17 hours for the 24mer. (E) Tissue Ab
concentration in vivo, calculated from measurements of Ab concentration in agarose. Each data point represents the mean and range from one
mouse (n=9 mice; 3–4 measurements per mouse). The line is a linear fit.
doi:10.1371/journal.pone.0015709.g005
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in the tissue. The tissue concentrations (averaged throughout the
depth of the slice) of monomer and 24mer both declined rapidly
towards steady-state concentrations (figure 8A). The time taken to
reach a steady-state concentration of Ab in the tissue was expressed
as the 90% completion time, defined as the time taken for the
concentration ofAb to declineby 90%of the differencebetween the
initial concentrationand the steady-stateconcentration.Thesteady-
state concentrations decreased and the 90% completion time
increased with increasing half-life (figure 8A and B). As half-life
tended towards infinity (no turn-over of Ab), the 90% completion
time tended towards asymptotes of 23.3 minutes for the monomer
and 66 minutes for the 24mer. Hence the model predicts that the
90% completion times in slices (in which there is turn-over of Ab)
are less than 23.3 minutes for monomer and 66 minutes for 24mer.
For a half-life of 0.64 hours, the predicted completion times were
18.3 minutes for monomer and 37.3 minutes for 24mer.
To measure the kinetics of the changes in Ab concentration
after slice preparation, each slice was placed in a small-volume
chamber, containing 250 ml of ACSF, immediately after prepara-
tion. The concentration of Ab1–42 in the ACSF was measured after
1 to 180 minutes in the well. The model (#4) predicts an initial
rapid increase in the concentrations of monomer (figure 8C) and
24mer (not shown) in the ACSF. This initial phase lasts less than
30 minutes (figure 8C). Thereafter the ACSF concentration
continues to rise approximately linearly, with the gradient
increasing with decreasing half-life of Ab (figure 8C).
In contrast to the predictions of the model, the measured Ab1–42
concentration decreased during the first hour after slice prepara-
tion. ACSF Ab1–42 concentration declined by approximately 40%,
from a peak of 4.560.85 pM at 5 minutes to 2.460.31 pM at
1 hour (P,0.05, paired t-test; figure 8B). Thereafter the ACSF
Ab1–42 concentration stabilized and possibly increased slightly
during the next hour (to 3.060.5 pM at 2 hours; not significantly
different from concentration at 1 hour).
This decline in ACSF Ab1–42 concentration with time was
unexpected. I considered whether this might be a methodological
artifact, such as binding of Ab to the plastic walls of the 24-well
plate. To test for this, measurements were repeated with a
recovery period in which each slice was placed in a large volume of
ACSF for 15 minutes before being transferred to the 24-well plate.
A methodological artifact, such as binding to plastic, would be
unaffected by the recovery period and the decline would therefore
persist. In contrast, much of the Ab1–42 from an initial elevation in
Ab1–42 would exit the slice within ,30 minutes, reducing the
Ab1–42 concentration in the first few wells and suppressing the
decline in Ab1–42.
Normalized ACSF concentrations of Ab1–42 were initially
(t#10 minutes) lower with than without the recovery step
(figure 8E) and the decline in ACSF Ab1–42 concentration with
time was eliminated. For both conditions, the Ab1–42 concentra-
tion increased gradually after 1 hour (figure 8E). Hence a
15 minute recovery period reduced the initial elevation and
subsequent decline in Ab1–42 concentration, indicating that the
changes in Ab1–42 concentration are not a methodological artifact.
Hence Ab1–42 was removed from the ACSF during the first hour
after slice preparation. Immediately after slice preparation the
extracellular diffusible Ab1–42 concentration therefore follows a
complex kinetic scheme: it initially increases, likely as a result of
release of Ab1–42 during slice preparation, and then declines over
the first 30–60 minutes before reaching a steady-state condition.
Why does the concentration of Ab1–42 in the ACSF decline with
time? Presumably Ab1–42 is taken-up by the tissue or catabolized
via one of the many pathways for enzymatic degradation of Ab1–42
[33]. Uptake and metabolism of Ab are incorporated into the
model through the half-life calculations. In the model, as Ab
concentration in the tissue declines, the balance between Ab
release/synthesis and Ab uptake/catabolism tips towards net
release/synthesis. This imbalance, along with diffusion of Ab,
results in the increase in ACSF Ab concentration with time
(figure 8C). The measured decline in Ab1–42 concentration
(figure 8D) suggests that uptake/catabolism and release/synthesis
are unbalanced in the other direction, resulting in net uptake/
catabolism. Such an unbalance might occur if the concentration of
Ab is elevated. Slicing brain tissue inevitably results in the death of
neurons, particularly near the cut surfaces of the slice, and dying
Figure 6. Ab release from slices after a recovery period. (A) Measurements of Ab1–42 concentration in ACSF as a function of recovery time for
postnatal day 132 and 163 mice (P132 and P163). Slices were maintained in a large volume of ACSF for 15 to 120 minutes (x-axis) then in 250 mlo f
ACSF for 30 minutes. Measurements were made from three Tg+ CRND8 mice of each age. Each data point represents mean 6 SEM. (B) Expected
normalized Ab concentrations in the ACSF and tissue, assuming a half-life for Ab of 1.28 hours. For simplicity, tissue concentrations were averaged
throughout the thickness of the slice. Results were derived from model #3, which was designed to mimic the experiment shown in panel A. The
model was run with three different effective diffusion coefficients for Ab. For comparison with the measured Ab1–42 concentrations in panel A,
normalized Ab concentrations were converted into absolute concentrations by multiplying by 234 pM, which is the concentration of Ab1–42
calculated from the in vivo measurements (figure 5E). The absolute concentrations therefore represent the concentrations of Ab1–42 expected in P163
mice and are shown using the right hand axis. The corresponding measurements (from panel A) are overlaid in grey.
doi:10.1371/journal.pone.0015709.g006
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synaptic activity, which can release Ab from synaptic terminals
[20,34]. Ab concentration may therefore be elevated immediately
following slice preparation.
Elevating the initial Ab concentration in the model resulted in a
decline in ACSF Ab concentration with time (figure 9). The
decline became faster and more pronounced as the initial Ab
concentration was increased and the half-life for Ab was decreased
(figure 9), but the decline predicted by the model was slow,
presumably because the slice occupies only a small proportion
(10%) of the volume of the chamber. Elevating the initial Ab
concentration in the model, even by several orders of magnitude,
failed to reproduce the observed rapid decline in ACSF Ab1–42
concentration. Hence release of Ab during slice preparation is
unlikely to entirely account for the decline in ACSF Ab
concentration during the first hour and additional factors, that
are not incorporated in the model, are likely responsible for the
decline in Ab1–42 concentration after slice preparation.
Kinetics of exogenous Ab accumulation in slices
Finally I used the model to calculate the rate at which Ab enters
a slice when the slice is bathed in ACSF containing exogenous Ab.
In this model (#5) the initial concentration of Ab in the slice was
set to zero and the concentration in ACSF to one (figure 10A). The
Figure 7. Effect of half-life on expected concentrations of Ab in ACSF and tissue. (A) Predicted normalized ACSF and tissue Ab
concentrations from model #3, corresponding to the experiments in figure 6A. Normalized and absolute concentrations of Ab are plot as a function
of the recovery time. As in figure 6, absolute concentrations are calculated for P163 mice and the measured ACSF concentrations at P163 (from
figure 6A) are overlaid in grey. Tissue Ab concentrations are averages of the Ab concentration throughout the thickness of the slice. The model was
run with four half-lives of Ab.( B) Steady-state normalized concentrations of Ab in ACSF and tissue as a function of half-life of Ab. Tissue Ab
concentration is an average of the Ab concentration throughout the thickness of the slice. Steady-state values were taken from the concentrations at
120 minutes recovery time, which approximates the true steady-state concentrations. (C) Predicted normalized concentrations of Ab as a function of
location in the slice with several different recovery periods and a half-life of Ab of 0.64 hours. Concentrations are plot as a function of location with
the center of the slice at x=0 and the edges of the slice at x=2150 and +150. Curves are shown for 3 or 4 pre-wash times (15, 30, 60 and
120 minutes).
doi:10.1371/journal.pone.0015709.g007
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the ACSF within 30 minutes (monomer) to 1 hour (24mer)
throughout the depth of the slice (figure 10B and 10C). Hence
diffusion of soluble Ab species in brain tissue not only results in the
rapid loss of endogenous extracellular Ab from slices, but also a
rapid rise in Ab concentration within the slice during the
application of exogenous Ab.
Discussion
I have measured extracellular Ab1–42 concentrations in vivo and
in acute brain slices from CRND8 mice. The extracellular
concentrations of Ab species have been measured previously in
the intact mouse brain by microdialysis and ELISA [30], but the
size of microdialysis probes precludes their use in acute slices,
which are only 200–400 mm thick. Instead I determined the
extracellular concentration of Ab1–42 in acute brain slices
indirectly, measuring the concentration of Ab1–42 released and
using a numerical model to calculate, from these measurements,
the extracellular concentration of diffusible Ab1–42 in the tissue.
My principal conclusion is that the concentration of Ab1–42 in
acute slices is reduced by the loss, by diffusion, of most of the
soluble extracellular Ab1–42. The steady-state concentration of
Ab1–42 in the slice was dependent on the parameters used in the
model, but the calculated Ab1–42 concentration was greatly
reduced across a wide range of model parameters. Near the
surfaces of the slice, the calculated steady-state Ab1–42 concentra-
tion was less than 20% of the concentration in vivo and even deep
within the slice the concentration was only ,20–30% of the in vivo
concentration.
Heterogeneous distribution of Ab and plaques in CRND8
mice
CRND8 mice carry two APP mutations (KM670/671NL
‘Swedish’ and V717F ‘Indiana’) and elevated levels of Ab in
hippocampus and through much of the neocortex from a young
age [35]. CRND8s develop many of the histological and cognitive
deficits of patients with AD, including amyloid plaques in
hippocampus and neocortex [16,35–37]. CRND8 mice do not
carry mutations in other genes or exhibit tau hyperphosphoryla-
tion or neurofibrillary tangles and are therefore an excellent model
in which to study the effects of Ab.
In my models I treated the slice as homogenous, but for slices
from CRND8 mice, hippocampus and neocortex are likely to be
the main sources of Ab released into the ACSF. Hippocampus and
neocortex together account for ,50% of the coronal slices used in
my experiments. Hence if little or no Ab is released from other
Figure 8. Kinetics of Ab concentration after slice preparation. (A) Normalized concentrations of Ab monomer and 24mer as a function of time
after slice preparation for several different half-lives of Ab, calculated using model #1. These are mean tissue concentrations, derived by averaging
the Ab concentrations throughout the slice. Lines are double exponential fits. (B) 90% completion time (time required for 90% of the decline in
concentration from the initial concentration to the steady-state concentration), plot as a function of the half-life of Ab.( C) Normalized ACSF Ab
monomer concentrations predicted with several different half-lives for Ab (model #4). Each line of best fit is the sum of an exponential and a linear
component. (D) Measurements of Ab concentration in ACSF as a function of time. Measurements were made from three 4 month-old Tg+ CRND8
mice (open symbols) and three 5 month-old Tg2 (wild-type) CRND8 mice (grey symbols). Each data point represents mean 6 SEM. (E) Comparison of
Ab accumulation in ACSF with and without a recovery step. Measurements after a 15 minute recovery (solid symbols) were made from three 5
month-old Tg+ CRND8 mice. Mean ACSF Ab concentration with the recovery period was 11.362.5 pM after 2 hours. For comparison with the results
from panel A (open symbols), ACSF Ab concentrations were normalized to that at 2 hours.
doi:10.1371/journal.pone.0015709.g008
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hippocampal and neocortical tissue might be higher than
calculated in the results. The loss of Ab from slices may therefore
occur more rapidly than suggested by my simplified models and
my calculations likely provide a conservative estimate of the rate of
Ab loss from acute slices.
Amyloid plaques first appear in the hippocampus and neocortex
of CRND8 mice at 2–3 months of age and the plaqueload increases
steadily thereafter. Most ofthe mice used herewere2–6monthsold,
ages at which the plaque load is light. Whether plaques affect
diffusion of soluble Ab species is unclear, but it is possible that the
increasing plaque load with age would impede diffusion of Ab and
retard loss of Ab from slices. However, given the relatively small
percentage of the total volume of hippocampus and neocortex
occupied by plaques, evenin old mice, it seems unlikely that plaques
would substantially alter diffusive loss of Ab from acute slices.
Figure 9. Effects of initial Ab concentration and half-life of Ab
on the ACSF Ab concentration. Predicted ACSF Ab concentrations
as a function of time in model #4. The model was run with four half-
lives of Ab for three elevated initial Ab concentrations in the tissue:
[Ab]=10 (A); [Ab]=100 (B); [Ab]=1000 (C).
doi:10.1371/journal.pone.0015709.g009
Figure 10. Diffusion of exogenous Ab into acute slices. (A) Initial
concentrations of Ab. Tissue-ACSF boundaries are at distances of +150
and 2150 mm. Initial concentration in the tissue is zero and in the ACSF
is 1, with the result that all concentrations in the model are normalized
to the initial concentration in the ACSF. (B) Concentrations of monomer
and 24mer at all locations in the brain slice (plot as a function of
distance from the center of the brain slice) at 1 second, 1 minute,
10 minutes, 30 minutes, 1 hour and 3 hours (C) Concentrations of
monomer and 24mer as a function of time at three different locations
within the brain slice. Distances (0, 50, 100 mm) are with respect to the
center of the slice.
doi:10.1371/journal.pone.0015709.g010
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Ab in aging tissue contribute to plaque deposition. My results do
not address this issue and this therefore remains an intriguing
possibility that requires further investigation.
Accuracy of the model and the half-life of Ab
The model benefits from being reasonably simple, with most
parameters available from publications. The initial model, which
used values or reasonable estimates from the literature, predicted
concentrations of Ab that are close to the measured concentra-
tions, indicating that the model is a good starting point from which
to consider loss of Ab from acute slices. Nevertheless, measured
steady-state ACSF concentrations of Ab1–42 were approximately
2-fold greater than the concentration predicted by the model.
What might account for this difference?
The principal variables in the model are the rate of diffusion
and the half-life of Ab. An error in the rate of diffusion is unlikely
to account for the difference between predicted and measured Ab
concentrations. Accurate values for the diffusion coefficient of Ab
and for the tortuosity factor, which accounts for restrictions on
diffusion in the extracellular space, are available in the literature
[25–28] and diffusion of fluorescent Ab1–42 is consistent with these
calculated rates of diffusion. No adjustment was made to account
for binding of Ab oligomers in the extracellular space, to excitatory
synapses for example [38], but binding would slow, not speed
diffusion of Ab species through the extracellular space and the
absence of binding in the model would therefore not result in an
underestimate of Ab release. Furthermore, changing the rate of
diffusion in the model had little effect on the amount of Ab
released from the slice. Hence changes in diffusion do not explain
the difference between initial model and measurements.
The half-life of Ab in the model is a more likely source of
inaccuracy as the half-lives of Ab species are less clear from the
literature. There are few published half-life measurements from
APP overexpressing mice. Measured half-lives range from 0.7 and
1.7 hours or less for Ab1–40 and Ab1–42, respectively (measured by
postmortem extraction of Ab from brain tissue [31]) to 4 hours
(measured by in vivo dialysis [30]). A half-life of 1.28 hours was
initially used in the model and 0.52–0.67 hours was found to more
accurately reproduce the measured concentration of Ab1–42
released from slices. 0.64 hours was therefore used to calculate
the concentrations of Ab1–42 in the tissue. 0.64 hours is towards
the shorter end of the range of published half-lives. However, the
published half-lives were based on in vivo measurements. Slice
preparation likely results in a temporary increase in neuronal
activity, which may increase release of Ab species, and the release
of Ab metabolizing enzymes from damaged cells. Hence the half-
lives of Ab species in slices are likely to be shorter than half-lives in
vivo.
A third possible explanation is that the initial concentration of
Ab1–42 in the slice is lower than expected. The expected value was
derived from the relationship between Ab1–42 concentration and
age in vivo. The in vivo measurements revealed enormous variability
in Ab1–42 concentrations between mice (figure 5E). The reason for
this variability is unclear, but presumably reflects differences in
APP expression and/or Ab accumulation between individual
mice. As a result, any individual mouse brain might contain far
more or far less Ab1–42 than an average mouse, opening the
possibility that the concentrations of Ab1–42 in the brains of mice
used in slice experiments were higher than the mean value from in
vivo experiments. If this were the case, a longer half-life for Ab
would be consistent with the measured release of Ab1–42 from
slices (the grey line would move downwards in figure 7A).
However, this would have very little effect on the steady-state
concentrations of Ab1–42 in slices and only a modest effect on the
rate at which this steady-state is approached (figure 8A and B).
The model failed to explain the rapid decrease in Ab1–42
concentration in ACSF in the first hour after slice preparation
(Figures 6C and 7). This failure might result from the manner in
which half-life was implemented in the model, as a constant rate of
Ab production and a constant percentage rate of elimination. In
slices, declining Ab concentration might stimulate Ab synthesis or
release, resulting in changes in the half-lives of Ab species through
time. A transient elevation in half-life could explain the rapid
decline in ACSF Ab1–42 concentration immediately after slice
preparation and might occur if Ab metabolizing enzymes are
released from damaged cells, transiently increasing the rate of Ab
clearance from the slice.
Other simplifications in the model could also contribute to the
difference between expected and measured Ab concentrations. For
example, in the model the tissue is considered homogeneous,
whereas diffusion of Ab is likely to differ between regions of the
slice, between white and grey matter for example. In addition, the
initial concentrations of Ab species are unlikely to be homoge-
neous throughout the brain. In CRND8 mice, APP overexpression
and Ab accumulation are pronounced in hippocampus and
neocortex [35]. These regions may be the principal source of Ab
released from the slice by diffusion, in which case loss of Ab1–42
from hippocampus and neocortex would have to be particularly
severe to elevate ACSF Ab1–42 to the measured concentrations
and the concentrations of Ab1–42 remaining in hippocampus and
neocortex in an acute slice would be lower than calculated here.
My calculations of the percentage loss of Ab from acute slices may
therefore be conservative estimates. Even these conservative
estimates indicate that the loss of Ab from acute slices is profound.
Effects of Ab1–42 on synaptic physiology
ELISA assays have been used previously to measure Ab
concentrations in the brains of mice overexpressing APP. Previous
measurements were made on homogenized tissue and therefore
include both intra- and extracellular Ab. In contrast, I measured
Ab1–42 that diffused from the brain into an overlying layer of
agarose in vivo. Hence the membranes of brain cells remained
intact and the measured concentration was of only extracellular
diffusible Ab1–42.
I concluded that the concentration of extracellular diffusible
Ab1–42 in CRND8 mice increases from 160 pM to 425 pM as
CRND8 mice age from 3 to 6 months. The plasma concentration
of Ab1–42 in 6 month-old CRND8 mice is 0.7–2 nM [36,39].
Plasma and cerebrospinal fluid concentrations of Ab are similar
[40–42]. Hence the in vivo Ab1–42 concentrations reported here are
consistent with previous measurements from CRND8 mice.
At these concentrations Ab affects long-term potentiation (LTP)
when applied to acute hippocampal slices. At high picomolar and
nanomolar concentrations Ab oligomers inhibit LTP (700 pM
[18]; 500 nM [19]; 200 nM [22]) whereas both inhibition and
enhancement have been reported with 50–200 pM Ab [22,24].
Hence the extracellular concentrations of soluble Ab1–42 in 2–6
month-old CRND8 mice, may enhance or suppress synaptic
plasticity in vivo.
Deficits in synaptic plasticity attributable to soluble Ab species
have also been observed in acute slices from CRND8 and other
APP overexpressing mice. Hence loss of soluble Ab from slices
does not eliminate all the effects of soluble Ab species on synaptic
transmission, perhaps because these effects of Ab are irreversible
or slowly reversible. However, the effects of extracellular soluble
Ab1–42 can occur within only a few minutes of exposure to Ab1–42.
If some of the effects of Ab are also rapidly reversible, these effects
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acute slices from 2–6 month-old CRND8 mice the effect on LTP
may be lost as the concentration of soluble extracellular Ab1–42
declines from 300–500 pM in vivo to 100 pM or less in slices. As
the mice age, and the soluble extracellular Ab1–42 increases, the
effects of loss of Ab may change. The rate at which loss of Ab
alters synaptic physiology in slices is unclear. Loss of Ab1–42 from
acute slices is rapid, but Ab molecules bind to plasma membranes
[38]. Hence Ab might remain bound to target molecules despite
the falling extracellular concentrations of diffusible Ab species.
I also estimated the rate of entry of exogenous Ab, applied in the
ACSF. The model predicts that exogenous Ab enters the slice
quickly, reaching a steady-state concentration equivalent to the
concentration in ACSF in 30 minutes to an hour. Unsurprisingly,
this time course is similar to that for loss of endogenous Ab. Turn-
over of Ab was not considered in the model of exogenous Ab
entry. Some authors have applied exogenous Ab at extremely high
concentrations, far higher than endogenous concentrations of Ab
(e.g. [43]). At these concentrations the relevant metabolic
pathways may be unable to significantly affect Ab concentration
and it is therefore unclear how to model turn-over in these cases.
Fortunately in my models the effect of turn-over on the rate of
change of concentration is relatively weak (see figure 8 A and B,
for example). My results suggest that effects of exogenously applied
Ab observed in less than 30–60 minutes are likely to result from
lower concentrations of Ab than those in the perfusing ACSF and
that this Ab must be acting extremely quickly. For example, effects
of exogenous Ab on synaptic plasticity have been reported
following application of only 50–200 pM exogenous Ab for
20 minutes (e.g. [22,24]). My results suggest that such effects
must result from a site of action which is exclusively on the surface
of the slice or from an extremely rapid action of lower
concentrations of soluble Ab species than are present in the
extracellular space in many APP mouse lines.
In summary, here I have shown that the concentration of
soluble Ab1–42 in the extracellular space declines during the first
hour after preparation of acute brain slices from CRND8 mice.
Electrophysiological recordings in acute slices are usually obtained
at least 30 minutes and often several hours after slice preparation.
Hence recordings in acute slices from APP overexpressing mice
are obtained when extracellular Ab is at a steady-state concen-
tration, which is far lower than the concentration of Ab in vivo.I n
acute slices prepared from CRND8 mice or other APP
overexpressing mouse lines, diffusive loss of Ab from the tissue
after slice preparation may eliminate or moderate some of the
effects of Ab, greatly complicating interpretation of physiology
experiments aimed at elucidating the effects of Ab.
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